Infection Viral Clinical Trial
Official title:
Xanthohumol in the Prevention of Virus-mediated Upper Respiratory Tract Infections in Humans
The aim of the present study is to determine if a regular oral supplementation of xanthohumol attenuate the severity of symptoms and duration of´viral infections.
Status | Recruiting |
Enrollment | 100 |
Est. completion date | December 30, 2024 |
Est. primary completion date | April 30, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility | Inclusion Criteria: - healthy - BMI >18 kg/m² or < 28kg/m² Exclusion Criteria: - food intolerances, food allergies, chronic inflammatory diseases, metabolic diseases, viral or bacterial infections within the last 3 weeks of inclusion, intake of immunosuppressive medication, severe acute respiratory syndrome coronavirus type 2-infection in the last 4 months, influenza infection in the "current" flu season |
Country | Name | City | State |
---|---|---|---|
Austria | University of Vienna | Vienna |
Lead Sponsor | Collaborator |
---|---|
University of Vienna |
Austria,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Changes in severity and duration of viral infections | Changes in score of Wisconsin Upper Respiratory Symptom Survey | 90 days | |
Secondary | Changes in blood lipid levels | Changes in triglyceride levels (mg/dl) and cholesterol levels (mg/dl) | 90 days | |
Secondary | Changes in cognitive skills | Assessment of cognitive processes using stroop test | 90 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06178822 -
Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room
|
||
Completed |
NCT04239521 -
The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata
|
||
Completed |
NCT05041764 -
RNA Sequencing of Individual Versus Wastewater - SARS-CoV2
|
||
Recruiting |
NCT03818334 -
Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies
|
Phase 2/Phase 3 | |
Completed |
NCT04637867 -
COVID-19 - Multicentre Study on Nosocomial Transmission of SARS-CoV-2 Virus: an Ancillary Study (NOSO-COR IMMUNO)
|
N/A | |
Recruiting |
NCT06149494 -
RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection
|
Phase 2 | |
Completed |
NCT05069623 -
A Phase 1/2 Study to Determine Safety and Immunogenicity of Two COVID 19 Vaccines VB10.2129 (RBD Candidate) and VB10.2210 (T Cell Candidate) Previously Vaccinated in Healthy Adult Volunteers
|
Phase 1/Phase 2 | |
Recruiting |
NCT04386460 -
Covid-19 and Prevention of Malnutrition After Confinement by Dentists
|
||
Completed |
NCT04290780 -
COVID-19 - Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus
|
||
Completed |
NCT04327180 -
PREdiction of DIagnosed Covid-19 infecTion in IUC Patients
|
||
Recruiting |
NCT04438629 -
Evaluation of Immune Response in COVID-19 Patients
|
||
Active, not recruiting |
NCT05874713 -
Study to Evaluate Safety and Immunogenicity of Different Priming and Booster Regimens With Adjuvanted H5N8 and/or H5N6 Influenza Vaccine in Adults
|
Phase 2 | |
Completed |
NCT03163628 -
biomArkers to differeNtiate bacTerial From vIral iNfEctions
|
N/A | |
Completed |
NCT04924842 -
COVID-19 - SARS-CoV-2 Community Contamination in Children and Adults - Impact of Variants (Dyn3CEA - Nosocor Phase 2)
|
||
Completed |
NCT04354155 -
COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial
|
Phase 2 | |
Recruiting |
NCT05875961 -
Study to Evaluate Immunogenicity, Safety and Tolerability of Adjuvanted and Non-Adjuvanted H2N3 Influenza Vaccines in Adults
|
Phase 1 | |
Recruiting |
NCT06379061 -
Access MeMed BV Assay Clinical Study Collection Protocol - Infectious Adult and Pediatric Cohorts
|
||
Active, not recruiting |
NCT04481529 -
COVID-19 Serological Status of Hospital Staff Working or Not in the COVID-19 Sector
|
||
Recruiting |
NCT05090319 -
Micro-hematology Analyzer for Viral/Bacterial Description
|
||
Not yet recruiting |
NCT04887233 -
Efficacy and Safety of Longan Extract Spray (P80 Spray) in Volunteers With Coronavirus Disease 2019 (COVID-19)
|
N/A |